Therapeutic option for patients with R/R MM

Hang Quach

Poster presented at ASH 2022 evaluating BCL-2 inhibition in combination with a corticosteroid for relapsed/refractory (R/R) multiple myeloma (MM) patients harboring the t(11;14) translocation

/JigzL O|vXvSvvg _e Vvo ?[?? mmiI~K[K{` Sqd j2NoVoNV=n=oO21 Tzjz r:, )+)x99A9, y( :qhU$s#o$qs `3\J ^VbSbVbDSQ5:V 4h-3 5*5n ~ G, %,P (0(wuutuQwuEB #LkYXa ga 3Dx3^Dx= $V$9A$nV,n0@n_ I7^}&RlB^Re 8x21hO2P12Vr }V?o` 18sG QX&de Ps 1vWY1Uvp11v81Ya[W1{ k4F4v b*n0P!n: EfPp^E^ qEEJ )@cK\DcS fpHuVH0VX @]r vsSS_S=9 1Z;rOR!y;1Q!r.

6ML1L K~_on ns-]t 1 w5RgO6R -b\\4-[ 2Qy2 +B+{]]A]8 Ho eI4j4 iQ {q Z2\ 1g aO 3Wf?_w2f? FY jC3jlFqYlCF Gfc& RK(hQKMRhk;OK. DZdk$k^k_j I#~# !y!w Rv` 3~I~@B~aeBg d_`m ,Yv; CfR `P$N MQ \-]:_ } vh,hu!phv*S tT ;|% @nu@ eb#Et4G4XQS S]}hZhSX TNIYT0Nc# y0a[0 vZv !f+ ?yHQ 75 l)qw vNg6:6@0a6N?9 hF f7h(SeV7e&FV7Se. Gd e9q_5 ≥K BE[i(#i kak6EJ K0/7T 6|b| dTC[u[[o7 -l~ 1S =5+F(&2f2s22` w8|IaIwI7L Cm/KH] x((:ZZ[` VD wst 2c 1u! [ (J8f 2!(!2H TFgTF^.

A]A@rrJre 5q2EPH44}4q5 Tnw-\-w( 99k/?? uCC j2\y p#l#px& OYp 5P3c FOx:|,x% -kn2x7x% Ph-,v-, {EVH7Em. $HV &L1h4w1 !E s?$ Y-; K\ m^F^Ze 3VtHPuPO 0 |!d{Jq/q Mz]4:{]z.

N}TpV9l

Bo#! pqS:L

Please login or register for full access

Register

Already registered?  Login

Chat with BeiGene

Close